Development and validation of Ran as a prognostic marker in stage I and stage II primary breast cancer-Reference-Cited by-同舟云学术

Development and validation of Ran as a prognostic marker in stage I and stage II primary breast cancer

Published:2023-09 Issue: Volume:329 Page:121964
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

El-Tanani Mohamed,Platt-Higgins Angela,Nsairat Hamdi,Matalka Ismail I.,Ahmed Khaled Abdul-Aziz,Zhang Shu-Dong,Alshaer Walhan,Awidi Abdalla,Matchett Kyle B.,Aljabali Alaa A.,Mishra Vijay,Serrano-Aroca Ángel,Tambuwala Murtaza M.,Rudland Philip S.

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference52 articles.

1. Recent discoveries of macromolecule- and cell-based biomarkers and therapeutic implications in breast cancer;Wu;Int. J. Mol. Sci.,2021

2. Molecular portraits of human breast tumours;Perou;Nature,2000

3. A systematic assessment of benefits and risks to guide breast cancer screening decisions;Pace;JAMA,2014

4. Ran GTPase in nuclear envelope formation and cancer metastasis;Matchett;Adv. Exp. Med. Biol.,2014

5. Ran GTPase: a key player in tumor progression and metastasis;Boudhraa;Front. Cell Dev. Biol.,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vivo evaluation of mebendazole and Ran GTPase inhibition in breast cancer model system;Nanomedicine;2024-04-25

2. A pan-cancer analysis of the prognosis and immune infiltration of eEF1A2 and its potential function in thyroid carcinoma;Heliyon;2024-02

3. Dual-loaded liposomal carriers to combat chemotherapeutic resistance in breast cancer;Expert Opinion on Drug Delivery;2024-01-31

4. Hyaluronic Acid – Coated Niosomes for Curcumin Targeted Delivery into Breast Cancer Cells;ChemistrySelect;2024-01-17

5. Corrigendum to “Development and validation of Ran as a prognostic marker in stage I and stage II primary breast cancer” [Life Sci., 329 (2023) 121964];Life Sciences;2023-10